Amy Grizzle, PharmD

Associate Director, HOPE Center

Amy Grizzle is the Associate Director of the Center for Health Outcomes and PharmacoEconomic Research. She joined the center in March 1999 after spending nearly seven years in the pharmaceutical industry.

Dr. Grizzle received her BS and PharmD from the University of Arizona College of Pharmacy and then completed a two-year pharmacoeconomic fellowship with the University of Arizona and Glaxo Inc. Following her fellowship, she joined the Global Pharmacoeconomics group at Syntex, which was later acquired by Roche, in Palo Alto, California. Her primary focus was in drug development phases I - III for disease areas such as Parkinson's disease, diabetic peripheral neuropathy, cytomegalovirus retinitis, fracture healing and benign prostatic hyperplasia.

In her position as Associate Director for the center, Dr. Grizzle develops and coordinates training and educational programs, and manages research projects. Some of her research efforts at the center have included studying the use of pharmacoeconomic information in managed care decision making, patient outcomes associated with integrative medicine primary care, and the costs of outcomes of drug-drug interactions.

Education & Post Graduate Training: 

BS, University of Arizona 
PharmD, University of Arizona